NCT06648824View on ClinicalTrials.gov

Study of How Mitapivat Affects Midazolam Blood Levels in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 17, 2024

Primary Completion Date

December 3, 2024

Study Completion Date

December 3, 2024

Conditions
Healthy Participants
Interventions
DRUG

Mitapivat

Oral tablets

DRUG

Midazolam

Oral syrup

Trial Locations (1)

75247

Fortrea Clinical Research Unit Inc., Dallas

Sponsors
All Listed Sponsors
lead

Agios Pharmaceuticals, Inc.

INDUSTRY